Our Seattle Forum co-hosts:
(Click on each logo to learn more.)
Cavendish's first BioHealth Impact Forum in the Pacific Northwest
Our eighteenth event in four years was our first in Seattle. Cavendish joined together with Intellectual Ventures and the University of Washington's Institute for Health Metrics and Evaluation, for a unique showcasing of Cavendish members and an introduction to the top biohealth and technology leadership, projects and initiatives in the Pacific Northwest.
Forum Schedule and Speakers
Thursday | October 4, 2018
2:00 PM - 2:45 PM | Intellectual Ventures Laboratory in Bellevue, Wash.
Registration will open for members at the Intellectual Ventures Laboratory in Bellevue. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more.
2:45 - 2:50 PM | J. Michael Moffat, Chairman, Cavendish Global
Cavendish Global Chairman, J. Michael Moffat, will welcome the audience to the Intellectual Ventures Laboratory and the Seattle Forum.
2:50 PM - 3:30 PM | Maurizio Vecchione, Executive Vice President, Global Good and Research, Intellectual Ventures
Maurizio Vecchione is executive vice president of Global Good and Research at Intellectual Ventures (IV). In this role, he oversees Global Good, IV’s collaboration with Bill Gates to invent and deploy technology specifically focused on improving life in developing countries, as well as the research and operations of the IV Laboratory and Institute for Disease Modeling. Mr. Vecchione most recently served as CEO of Arrogene, which is commercializing a new nanotechnology platform for cancer-targeted therapeutics and diagnostics, and as CEO of telemedicine pioneer CompuMed.
3:30 PM - 4:15 PM | Moderated by Dena Morris, President & CEO, Washington Global Health Alliance
Dena Morris will lead a panel discussion with global health leaders from around Seattle and Washington State, on the latest initiatives, trends and discussions taking place in the nation’s leading global health hub, and the implications for key stakeholders. Panelists include:
Elizabeth Aylward, PhD, Director, Office of Science-Industry Partnerships at Seattle Children’s Research Insitute
Thomas S. Uldrick, MD, Deputy Program Head, Global Oncology Program, Fred Hutchinson Cancer Research Center
Scott Maloney, Director of Innovation and Private Sector Research Engagement, College of Veterinary Medicine, Washington State University
Rhea Coler, PhD, Senior Vice President, Infectious Disease Research Institute, University of Washington
4:15 PM - 4:45 PM | Praveen Raja, PhD, Vice President, Technology Development and Introduction, PATH
Dr. Raja oversees PATH’s Medical Devices and Tools, Diagnostics, and Global Innovation Hub teams in leveraging technology to improve health outcomes for underserved communities around the world. He has extensive experience in the development and commercialization of innovative medical devices, diagnostics, pharmaceuticals, and digital health tools that have achieved clinical adoption and commercial success globally. Dr. Raja has developed and led teams focused on innovation in start-up environments as well as in multibillion-dollar global companies and franchises.
4:45 - 5:15 PM | Featuring renown musicians, former Incubus guitarist, Michael Einziger, together with his wife and acclaimed violinist, Ann Marie Simpson, with a fireside chat moderated by Dr. Jonathan Sackier, Chief Medical Officer and Managing Partner, Cavendish Global
Ahead of the Opening Cocktail Reception, guests will be treated to an exclusive musical performance, featuring a unique discussion with Cavendish Global’s Dr. Jonathan Sackier.
5:15 PM - 8:00 PM | Intellectual Ventures Laboratory
The opening reception is a member favorite. Join new and returning members for an evening of uninterrupted networking and meeting at the Intellectual Ventures Laboratory.
The IV Laboratory will be providing members with exclusive tours of their facilities and current projects.
This is a can’t-miss evening!
Friday | October 5, 2018
7:30 AM - 8:10 AM | Location at UW Medicine to be announced!
Registration will open for members at the UW Medicine South Lake Union Campus in Seattle. Meet with our Forum Services team to review the Forum schedule, speakers, and work with our Digital Services team to set up your Cavendish IQ profile, schedule one-on-one meetings and more.
8:05 AM - 8:15 AM | Carlos A. Pellegrini, MD, Chief Medical Officer, UW Medicine; with an introduction from J. Michael Moffat, Chairman, Cavendish Global
UW Medicine’s Chief Medical Officer, Carlos A. Pellegrini, MD, will open the second day of the Seattle Forum on the South Lake Union campus of UW Medicine. Dr. Pellegrini will be introduced by Cavendish Global Chairman, J. Michael Moffat.
8:15 AM - 8:45 AM | Christopher J. L. Murray, MD, DPhil, Professor, IHME; Director and Chair, Department of Health Metrics Sciences
Christopher J.L. Murray, MD, DPhil, is the Director of the Institute for Health Metrics and Evaluation (IHME) and Professor of Global Health at the University of Washington. A physician and health economist, Dr. Murray is widely regarded as one of the founders of modern population health measurement, and his work has helped shape public policy in countries around the world.
Dr. Murray created the concept of the Global Burden of Disease with Dr. Alan Lopez while working as a professor at the Harvard School of Public Health. Dr. Murray led the coordination of the Global Burden of Disease Study 2010, the most comprehensive assessment to date of levels and trends in health worldwide. He served as the Executive Director of the World Health Organization’s Evidence and Information for Policy Cluster, where he pioneered the groundbreaking World Health Report 2000, in collaboration with Dr. Julio Frenk. Dr. Murray played a key role in the creation of the 1993 World Development Report, considered a touchstone for all subsequent attempts to study the effects of health policy and health investment on health outcomes. He returned to Harvard to help launch the Harvard Initiative for Global Health (now the Harvard Institute for Global Health) as its first director.
Dr. Murray’s work has been cited more than 50,000 times by other researchers in published articles. He holds Bachelor of Arts and Science degrees from Harvard University, a DPhil from Oxford University, and a medical degree from Harvard Medical School.
Dr. Murray and Dr. Frenk founded IHME in 2007. By measuring health, tracking program performance, finding ways to maximize health system impact, and developing innovative measurement systems, IHME provides a foundation for informed decision-making that ultimately will lead to better health globally.
8:45 AM - 9:45 AM | Cavendish Innovation Partners
Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.
9:45 AM - 10:30 AM | Orin Smith Conference Center at UW Medicine
Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.
Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.
10:30 AM - 11:00 AM | Featuring Sarah Lucas, Co-Founder & CEO, Beyond Type 1, interviewed by Rachel Butler, Executive Director, Cavendish Impact Foundation
Sarah is the CEO of Beyond Type 1, a nonprofit organization leveraging the power of social media and technology, changing what it means to live with a chronic condition. In just three years, her team has built a powerhouse global brand with the largest digital audience of any diabetes organization in the world. The result is improved health outcomes for millions of people, new opportunities to partner with iconic brands and the ability to consolidate other non-profits for greater impact. Sarah will discuss how venture capital, the tech and design worlds and traditional non-profit practices influenced the building of this new brand of philanthropy.
11:00 AM - 11:30 AM | Featuring Brian Slizgi, Director, Pharma R&D Advisory, PwC
Brian Slizgi, PwC Director of Pharma R&D Advisory will discuss the latest trends around the application of blockchain technology in biohealth, including opportunities and challenges for early-stage companies.
11:30 AM - 12:00 PM | Featuring James Lumberg, Co-Founder & EVP, Envestnet, together with James Patrick, Co-Founder & EVP, Envestnet, and Chairman of the Cavendish Impact Foundation
Details to be announced!
12:00 PM - 1:15 PM | Orin Smith Conference Center and surrounding lounge areas
Break bread with fellow Cavendish members and leaders from the University of Washington over a casual buffet lunch at UW Medicine. Cavendish luncheons do not feature keynote speakers, leaving attendees uninterrupted to network, meet and dine.
1:15 PM - 1:45 PM | Moderated by Peter McCrea, President, Cavendish Impact Foundation, together with Timothy Freundlich, President, ImpactAssets
In this fourth installment of a continuing panel series on impact investing, the Cavendish Impact Foundation's Peter McCrea joins philanthropic partner, ImpactAssets' President, Timothy Freundlich, to discuss the latest strategies in impact investment using philanthropic capital, and how to approach and participate in transactions from the standpoints of donors and innovators.
1:45 PM - 2:15 PM | Charles (Chuck) E. Murry, MD, PhD, Director, UW Institute for Stem Cell and Regenerative Medicine; Co-Director, UW Center for Cardiovascular Biology; Co-Director, UW Medicine Heart Regeneration Program
Dr. Murry’s research focuses on stem cell biology, with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues. His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy.
2:15 PM - 3:15 PM | Cavendish Innovation Partners
Cavendish Innovation Partners, early-stage biohealth companies, will deliver impact presentations on their latest breakthroughs.
(Image: David Huizenga, CEO, Moterum Technologies)
3:15 PM - 4:00 PM | Orin Smith Conference Center at UW Medicine
Immediately following Innovation Partner impact presentations, members enjoy a break to grab coffee, meet one-on-one with fellow attendees and continue conversations with Innovation Partners on the details of their presentations.
Meetings may be set in advance on the Cavendish IQ digital platform. Interested in joining Cavendish IQ? Contact Gwen Snyder.
4:00 PM - 4:30 PM | Featuring Ramona Hicks, PhD, Science and Technology Director, One Mind
At One Mind, Dr. Hicks works to facilitate the exchange of scientific knowledge across neuropsychiatric disorders, international borders, and academic and commercial entities to accelerate the development of diagnostic tools, biomarkers, and effective treatments. Projects include developing the One Mind Portal into a user-friendly and useful tool for research collaboration, especially among large, multi-center studies, implementing an evidence-informed screening and management tool for concussion in emergency departments (Screen-Inform-Prevent), and exploring opportunities for a public-private psychosis research initiative.
4:30 PM - 5:00 PM | Heather Mefford, MD, PhD, Director, Mefford Laboratory, Division of Genetic Medicine, University of Washington
Dr. Mefford is a physician at Seattle Children’s Hospital and an Associate Professor of Pediatrics at the University of Washington. She directs a research laboratory in the Division of Genetic Medicine that is devoted to gene discovery in pediatric disorders, with a focus on severe pediatric epilepsies. The Mefford Lab has identified numerous new epilepsy genes, which are now tested in the clinical setting. She has also been a key member of international consortium efforts for epilepsy gene discovery. Her clinical interests parallel her research interests and include seeing patients with suspected genetic disorders, pediatric epilepsies and neurocognitive defects of unknown causes.
5:00 PM - 8:00 PM | UW Medicine Orin Smith Lounge and surrounding areas
General Session programming will close with an immediate opening of the Evening Cocktail Reception. The UW Medicine reception will feature exclusive tours of research laboratories, along with interactive technology showcased by the Institute for Health Metrics and Evaluation!
Cavendish and Forum partners will deliver remarks, repeat the call for greater collaboration, innovation and impact, and highlight the upcoming 2019 San Francisco Forum in February. Be sure to check in with the Cavendish team on unique local dinner destinations to continue the conversations, post-Forum!